Compare
Cardinal Health vs Johnson & Johnson (CAH vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Cardinal Health (CAH) returned +38.1% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +32.2% and +33.5%.
Johnson & Johnson is the larger company by market value, about 10.6 times the size of Cardinal Health.
On trailing earnings, CAH trades at 37.6 times and JNJ at 41.9 times.
Revenue grew +14.2% at CAH and +7.8% at JNJ over the last year.
CAH yields 0.57%. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| CAH | JNJ | |
|---|---|---|
| Price | $271.72 | $276.22 |
| 1-day | +1.46% | +1.43% |
| YTD | +32.22% | +33.47% |
| 1 year | +38.08% | +48.51% |
| 3 years | +190.36% | +85.77% |
| Market cap | $62.8B | $665.0B |
| P/E | 37.6 | 41.9 |
| P/S | 0.25 | 6.69 |
| P/B | — | 8.16 |
| Revenue growth | +14.20% | +7.80% |
| EPS growth | — | -36.40% |
| Gross margin % | 3.8 | 67.6 |
| Net margin % | 0.7 | 16.2 |
| ROE % | — | 19.7 |
| Debt / equity | — | 0.55 |
| FCF yield % | 7.2 | 3.1 |
| Dividend yield % | 0.57 | 1.91 |
| Beta | -0.02 | -0.09 |
| RSI (14) | 73.8 | 59.4 |
| Technical rating |